Study | Year | Country of origin | Tumor type | Sample size | NNT-AS1 expression | Follow-up months | Detection assay | Clinical stage | Metastasis analysis | Outcome measure | Survival analysis | Cut-off value | NOS | Ref. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | ||||||||||||||
Gu, Y et al | 2019 | China | Cholangiocarcinoma | 98 | N/A | N/A | 60 | qRT-PCR | TNM I-III | DM | OS | Multivariate | Mean | 8 | [20] |
Huang, L et al | 2019 | China | Cholangiocarcinoma | 48 | 27 | 21 | 36 | qRT-PCR | TNM I-IV | LNM | OS | Univariate | Median | 8 | [26] |
Wu, D et al | 2019 | China | Bladder cancer | 47 | 24 | 23 | 60 | qRT-PCR | TNM I-IV | LNM | OS | Univariate | Median | 8 | [27] |
Chen, B et al | 2018 | China | Gastric cancer | 48 | 27 | 21 | 60 | qRT-PCR | TNM I-IV | LNM | OS | Univariate | Median | 7 | [28] |
Gu, Y et al | 2018 | China | Gastric cancer | 77 | 39 | 38 | 65 | qRT-PCR | TNM I-IV | LNM | OS | Univariate | Mean | 8 | [29] |
Ye, H et al | 2018 | China | Osteosarcoma | 126 | 63 | 63 | 80 | qRT-PCR | Enneking IA-III | DM | OS/DFS | Univariate | Median | 7 | [15] |
Li, Y et al | 2018 | China | Breast cancer | 64 | 32 | 32 | 60 | qRT-PCR | TNM I-III | N/A | OS | Multivariate | Mean | 8 | [19] |
Lu, Y et al | 2017 | China | Hepatocellular cancer | 42 | 23 | 19 | 50 | qRT-PCR | TNM I-IV | LNM | OS | Univariate | Median | 7 | [18] |
Wang, Q et al | 2017 | China | Colorectal cancer | 70 | 35 | 35 | 39 | qRT-PCR | TNM I-IV | LNM/DM | OS/PFS | Multivariate | Median | 9 | [21] |
Hua, F et al | 2017 | China | Cervical cancer | 79 | 40 | 39 | 60 | qRT-PCR | FIGO Ib-IIIa | LNM | OS | Univariate | Median | 8 | [30] |